+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ceftobiprole"

Cephalosporin Market Report 2025 - Product Thumbnail Image

Cephalosporin Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antibiotics and Antimycotics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel, and Geography - Product Thumbnail Image

Antibiotics and Antimycotics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel, and Geography

  • Report
  • November 2024
  • 203 Pages
  • Global
From
Cephalosporin Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) - Product Thumbnail Image

Cephalosporin Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • Report
  • July 2021
  • 120 Pages
  • Global
From
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 65 Pages
  • Global
From
Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 47 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Ceftobiprole is an antibiotic used to treat a variety of bacterial infections. It is a cephalosporin antibiotic, which works by inhibiting the growth of bacteria. Ceftobiprole is used to treat infections caused by Gram-positive and Gram-negative bacteria, including skin and soft tissue infections, respiratory tract infections, and urinary tract infections. It is also used to treat infections caused by certain anaerobic bacteria. Ceftobiprole is available in both oral and intravenous formulations. Ceftobiprole is a relatively new antibiotic, and is not yet widely used. It is approved for use in the United States, Canada, and Europe, and is currently being studied for use in other countries. Ceftobiprole is generally well-tolerated, with few side effects. Companies in the Ceftobiprole market include Merck & Co., Inc., Janssen Pharmaceuticals, Inc., and Basilea Pharmaceutica International Ltd. Show Less Read more